semaglutide 25 Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) related medical problems Tirzepatide vs. Semaglutide: Which is

Understanding how long GLP-1 approaches take to start working helps set realistic expectations for any method you choose

Zhou C, Wu L, Fan Y, Wang Z, Liu L, Chen G, et al

Guidance shifting toward individualized care Recent national guidance from several medical societies now recommends a tailored approach in which most patients can continue GLP-1 medications before surgery

N Engl J Med (2021) 385:50315

General practitioners are increasingly initiating these therapies, often in response to patient demand or as part of broader cardiometabolic risk management

What happens when you stop each medication Weight regain after stopping weight loss medications is a reality for both classes, but the dynamics differ